HIGHLIGHTS
- who: Sasivimon Pramual and collaborators from the Laboratory of Biochemistry, Chulabhorn Research Institute, Laksi, Bangkok, Thailand Mahidol University, Ratchathewi, Bangkok, Thailand have published the research work: PLGA-Lipid Hybrid Nanoparticles for Overcoming Paclitaxel Tolerance in Anoikis-Resistant Lung Cancer Cells, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
- what: The authors aimed to apply PLHNPs to improve the effectiveness of the therapeutic effect of paclitaxel towards anoikis-resistant lung cancer cells during metastasis.
- how: These results indicated that the PLHNP platform markedly improved the effectiveness of paclitaxel in anoikis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.